Provider of single-cell multi-omics analysis platform for researchers. The company specializes in building tools and generating insights at the interface of biology, chemistry, and engineering. It offers multi-omic assays and the study of mechanistic insights into the RNA regulatory layer. Founded in 2021, headquartered in San Diego, United States. The company has raised $31.0M in funding at the series a stage. The team comprises 30 (Jun 30, 2026) employees. The company operates in the Genomics sector with additional focus on Life Sciences Platforms and Tools. Its business model centers on Single Cell Genomics. Founded in 2021, headquartered in San Diego, United States. The company has raised $31.0M at the Series A stage. Backed by investors including Prime Movers Lab, BlueYard, KOFA Healthcare Investments, Global Brain, FoundersX Ventures and others.
Zafrens
Series AProvider of single-cell multi-omics analysis platform for researchers. The company specializes in building tools and generating insights at the interface of biology, chemistry, and engineering. It offers multi-omic assays and the study of mechanistic insights into the RNA regulatory layer. Founded in 2021, headquartered in San Diego, United States. The company has raised $31.0M in funding at the series a stage. The…
About
Business model
Genomics > Enabling Technologies > Instrument Systems > Single Cell Genomics,
Life Sciences Platforms and Tools > Instruments > Cell Biology > Cell Analysis > Single Cell Multi Omics
Institutional investors
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Backed by funds in our directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.